Cargando…
PTHrP and breast cancer: more than hypercalcemia and bone metastases
Parathyroid hormone-related protein (PTHrP) causes hypercalcemia in cancer patients. PTHrP is required for normal breast development and has been shown to promote bone metastases from breast cancers. However, whether the protein also contributes to the formation of primary tumors has been unclear. T...
Autores principales: | Boras-Granic, Kata, Wysolmerski, John J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446368/ https://www.ncbi.nlm.nih.gov/pubmed/22546075 http://dx.doi.org/10.1186/bcr3129 |
Ejemplares similares
-
Deletion of the Nuclear Localization Sequences and C-Terminus of PTHrP Impairs Embryonic Mammary Development but also Inhibits PTHrP Production
por: Boras-Granic, Kata, et al.
Publicado: (2014) -
PTHrP induces STAT5 activation, secretory differentiation and accelerates mammary tumor development
por: Grinman, Diego Y., et al.
Publicado: (2022) -
SAT-153 PTHrP Mediated Hypercalcemia
por: Arguello, Mingxue
Publicado: (2020) -
A Case of Hypercalcemia from PTHrP-Producing Fibromyxoid Sarcoma Responsive to Glucocorticoid Therapy
por: Niu, Isabella, et al.
Publicado: (2023) -
PSAT208 A Case of Hypercalcemia From PTHrP-Producing Fibromyxoid Sarcoma Responsive to Glucocorticoid Therapy
por: Niu, Isabella, et al.
Publicado: (2022)